You are here:
PUBLIC HEALTH AIR SURVEILLANCE EVALUATION (PHASE) - A SUMMARY
Citation:
DIMMICK, F. PUBLIC HEALTH AIR SURVEILLANCE EVALUATION (PHASE) - A SUMMARY. Presented at European Comission, Directorate General Environment, and French Agency for Environmental and Occupational Health Safety, Research Triangle Park, NC, January 25, 2006.
Impact/Purpose:
The primary study objective is to quantify the association between day-to-day or experimental variations in ambient air particle mass concentration and selected physiological functions in moderate/severe asthmatic children and adults. The NERL will conduct exposure studies and provide integrated PM mass concentration data to assist the NHEERL collaborators conducting physiological monitoring in establishing selected health effect associations resulting from potential human exposures to PM-related air pollutants. Ambient-based data will be collected to provide source apportionment data pertinent to comparing ambient versus concentrated air pollution (CAP) chamber studies.
Description:
NERL's Human Exposure and Atmospheric Sciences Division and other participants in the Public Health Air Surveillance Evaluation (PHASE) project will be discussing their results with European Commission, Directorate General Environment, and
French Agency for Environment and Occupational Health Safety in RTP, NC on January 25, 2006. The PHASE project is a collaboration between the EPA, CDC and the States of Maine, New York and Wisconsin. The objective of this collaboration is to develop, evaluate, and demonstrate the advantages and limitations of different methods of generating air quality characterization surveillance data that could be systematically and routinely available to link with public health surveillance data as part of the CDC's Environmental Public Health Tracking Network. EPA has provided air quality data for ozone and fine particles based on ambient air monitors, an application of the EPA/NOAA Community Multiscale Air Quality model, and statistically developed estimates.